The global antimicrobial (enzymatic) protein hydrolysates for food & pet food applications market is set to witness massive growth through 2028 owing to increasing usage of peptides in animal nutrition. In addition, the surge in intensive farming, which relies heavily on the regular use of antimicrobials to boost productivity, is also expected to spur market expansion over the forecast timeframe.

Microbial protein hydrolysis is a practical way of developing high-quality peptides, which have vital physiological and nutritional functions in poultry, livestock, and fish. Some peptides that are derived from plants are high in antioxidants and have antimicrobial and immunomodulatory characteristics, which makes them ideal for use in food and pet food.

Notably, industry players have been adopting profitable strategies to improve their business presence, enhancing overall dynamics of the global antimicrobial (enzymatic) protein hydrolysates for food & pet food applications market. For instance, in February 2022, Bio-Marine Ingredients (BMI), an Ireland-based supplier of advanced nutritional & functional ingredients, raised $7.4 million through a loan note. The company is focusing on the farmed fish and shrimp sectors in Southeast Asia with the aim of expanding the reach of its protein hydrolysates offerings, which have better digestibility than conventional fishmeal sources, in the aquaculture market.

For extensive assessment, the global antimicrobial (enzymatic) protein hydrolysates for food & pet food applications market has been bifurcated on the basis of form, application, source, and region.

On the basis of source, the market has been divided into micro-organisms, plant, and animal. The micro-organisms segment has been further segmented into fungi, algae, and others. The fungi segment is expected to grow at approximately 10% CAGR through the forecast timeframe. The others micro-organisms source segment is poised to register a CAGR of over 9% between 2022 and 2028.

The plant segment has been further classified into rice, soybeans, chickpea, common beans, and others. The chickpea segment and the rice segment are anticipated to register a CAGR of around 9.5% through the study timeline. The common beans segment is set to depict a CAGR of about 9% from 2022 to 2028. The others plant source segment is slated to grow at above 8.5% CAGR over the review timespan.

On the regional front, the antimicrobial (enzymatic) protein hydrolysates for food & pet food applications market in Latin America is projected to showcase robust expansion at a CAGR of nearly 9.5% through 2028. Meanwhile, the Middle East & Africa antimicrobial (enzymatic) protein hydrolysates for food & pet food applications industry is foreseen to exhibit steady progress at roughly 8% CAGR over the analysis time period.